HealthEquity (NASDAQ:HQY) Releases Earnings Results, Misses Expectations By $0.16 EPS

HealthEquity (NASDAQ:HQY) posted its quarterly earnings data on Tuesday. The company reported $0.55 earnings per share for the quarter, missing the consensus estimate of $0.71 by ($0.16), Zacks reports. HealthEquity had a return on equity of 9.70% and a net margin of 8.41%.

HealthEquity Stock Performance

HQY stock traded up $0.89 during trading hours on Tuesday, hitting $101.61. 1,504,246 shares of the stock were exchanged, compared to its average volume of 661,041. HealthEquity has a 12 month low of $65.01 and a 12 month high of $115.59. The firm has a market capitalization of $8.81 billion, a P/E ratio of 93.22, a P/E/G ratio of 1.60 and a beta of 0.62. The company has a 50-day simple moving average of $105.76 and a two-hundred day simple moving average of $95.51. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51.

Insider Transactions at HealthEquity

In other news, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the sale, the director now owns 78,219 shares of the company’s stock, valued at approximately $8,704,992.51. This represents a 6.85 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 2.20% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on HQY shares. Raymond James lifted their price objective on shares of HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a report on Tuesday, February 25th. Royal Bank of Canada lifted their price target on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Tuesday, December 10th. JMP Securities increased their price objective on shares of HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research note on Tuesday, December 10th. Mizuho assumed coverage on HealthEquity in a research report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 target price on the stock. Finally, Wells Fargo & Company increased their price target on HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research report on Wednesday, February 26th. One equities research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat.com, HealthEquity currently has an average rating of “Moderate Buy” and a consensus price target of $112.92.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.